South Africa: Government Is Considering Providing a Vaccine to Protect Babies From RSV

South Africa: Government Is Considering Providing a Vaccine to Protect Babies From RSV

Blog - A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on immunisations has recommended making it available to all pregnant women. This proposal is now under review by the National Department of Health.

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

GSK looks to compete with Pfizer and Moderna in the 18-49 age group of the RSV vaccine market in the US.